Form 485BXT NORTHERN FUNDS
As filed with the Securities and Exchange Commission on November 3, 2026
Securities Act of 1933 Registration No. 33-73404
Investment Company Act of 1940 Registration No. 811-08236
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
REGISTRATION STATEMENT
UNDER
| THE SECURITIES ACT OF 1933 | ☒ | |
| Pre-Effective Amendment No. | ☐ | |
| Post-Effective Amendment No. 217 | ☒ |
and/or
REGISTRATION STATEMENT
UNDER
| THE INVESTMENT COMPANY ACT OF 1940 | ☒ | |
| Amendment No. 219 | ☒ |
(Check appropriate box or boxes)
NORTHERN FUNDS*
(Exact Name of Registrant as Specified in Charter)
50 South LaSalle Street
Chicago, Illinois 60603
(Address of Principal Executive Offices)
800-595-9111
(Registrant’s Telephone Number, including Area Code)
| Name and Address of Agent for Service: | with a copy to: | |
| Michael Mabry Joel D. Corriero Stradley Ronon Stevens & Young, LLP 2005 Market Street Suite 2600 Philadelphia, Pennsylvania 19103 |
Jose J. Del Real Kevin P. O’Rourke The Northern Trust Company 50 South LaSalle Street Chicago, Illinois 60603 |
It Is Proposed That This Filing Become Effective (Check Appropriate Box):
| ☐ | immediately upon filing pursuant to paragraph (b) |
| ☒ | on December 2, 2026 pursuant to paragraph (b) |
| ☐ | 60 days after filing pursuant to paragraph (a)(1) |
| ☐ | On (date) pursuant to paragraph (a)(1) |
| ☐ | 75 days after filing pursuant to paragraph (a)(2) |
| ☐ | On (date) pursuant to paragraph (a)(2) of Rule 485 |
If appropriate, check the following box:
| ☒ | This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
* This filing relates solely to the Northern Trust US Gigawatt ETF.
Explanatory Note
This Post-Effective Amendment No. 217 under the Securities Act of 1933, as amended (the “Securities Act”) (Amendment No. 219 under the Investment Company Act of 1940, as amended (the “1940 Act”)) to the registration statement on Form N-1A (the “Registration Statement”) of Northern Funds (the “Registrant”) is being filed pursuant to paragraph (b)(1)(iii) of Rule 485 under the Securities Act solely for the purpose of delaying, until December 2, 2026, the effectiveness of the Registration Statement with respect to the Northern Trust US Gigawatt ETF (the “Fund”), initially filed in Post-Effective Amendment No. 209 on August 21, 2026, pursuant to paragraph (a)(2) of Rule 485 under the Securities Act, which would have become effective on November 4, 2026.
This Post-Effective Amendment No. 217 incorporates by reference the information for the Funds contained in Parts A, B, and C of Post-Effective Amendment No. 209.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the Investment Company Act of 1940, as amended, the Registrant certifies that it meets all of the requirements for effectiveness of this Post-Effective Amendment No. 217 to its Registration Statement under Rule 485(b) under the Securities Act and has duly caused this Post-Effective Amendment No. 217 to its Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the City of Chicago and State of Illinois on the 3rd day of November, 2026.
| NORTHERN FUNDS | ||
| By: | /s/ Kevin P. O’Rourke | |
| Kevin P. O’Rourke | ||
| President | ||
Pursuant to the requirements of the Securities Act this Post-Effective Amendment No. 217 to Registrant’s Registration Statement has been signed below by the following persons in the capacities and on the date indicated.
| Name |
Title |
Date | ||
| /s/ Kevin P. O’Rourke Kevin P. O’Rourke |
President (Principal Executive Officer) | November 3, 2026 | ||
| /s/ Randal E. Rein Randal E. Rein |
Treasurer (Principal Financial Officer and Principal Accounting Officer) |
November 3, 2026 | ||
| * Therese M. Bobek Therese M. Bobek |
Trustee | November 3, 2026 | ||
| * Thomas A. Kloet Thomas A. Kloet |
Trustee | November 3, 2026 | ||
| * William Martin William Martin |
Trustee | November 3, 2026 | ||
| * David R. Martin David R. Martin |
Trustee | November 3, 2026 | ||
| * Mary Jacobs Skinner Mary Jacobs Skinner |
Trustee | November 3, 2026 | ||
| * Ingrid LaMae A. de Jongh Ingrid LaMae A. de Jongh |
Trustee | November 3, 2026 | ||
| * Paula Kar Paula Kar |
Trustee | November 3, 2026 | ||
| /s/ Kevin P. O’Rourke * By Kevin P. O’Rourke Attorney-In-Fact |
||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
- Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen
- IGT and MGM Springfield Launch First Wide-Area Progressive Jackpot Games in Massachusetts
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!




Tweet
Share